Dr. Óscar González, consultant at Valme Hospital and member of the Functional Urology Unit, reflects on the potential of NESA technology in addressing different functional urological conditions, especially those in which the autonomic nervous system may play a relevant role.
In his testimony, he points out that this technology can open new perspectives in the treatment of conditions such as overactive bladder, inflammatory bladder disease and painful bladder syndrome, as well as certain sexual dysfunctions including ejaculatory dysfunction and erectile dysfunction. From his point of view, this is a clinical field with great room for development.
Dr. González also emphasizes that functional urology remains an area in which many questions remain to be solved and many patients for whom there is still no definitive response. In this context, he considers it essential to continue exploring innovative therapeutic alternatives that allow progress toward more effective and personalized approaches.
He also reminds us that pharmacological treatments have significant limitations, both due to their variable effectiveness and the high dropout rate associated with side effects. He therefore advocates for promoting new treatment pathways and positions NESA technology as one of the most promising options within this clinical innovation landscape.
